MicroMir

MicroMir (Russian: НПЦ «Микромир», the Scientific and Production Centre MicroMir) is a Russian company based in Moscow that develops and markets a line of bacteriophage-based health care gels. Its product range is built around the idea of using bacteriophages — naturally occurring viruses that attack specific bacteria — as an alternative or complement to antibiotics for protecting the human microbiome. The company positions itself as a research-and-production centre whose microbiologists select phage cocktails targeted at the bacteria most commonly responsible for infections in particular body sites. The flagship line consists of four gels, each formulated with a different cocktail of bacteriophages: Otofag (Отофаг), a 50 ml gel with 74 phages for the hygiene and protection of the ear, nose and throat; Fagodent (Фагодент), a 50 ml gel with 73 phages for oral hygiene and protection against gingivitis, stomatitis, periodontitis and periodontosis; Fagoderm (Фагодерм), a 50 ml gel with 73 phages for the care of oily, damaged and problem skin; and Fagogin (Фагогин), a 50 ml gel with 70 phages for everyday intimate hygiene for women and men, aimed at bacterial vaginosis, vaginitis, cystitis, cervicitis and urethritis. MicroMir markets its products as a natural solution that normalises the microbiome and provides antibacterial protection, and states that the gels can be used alongside antibiotics. The company emphasises that phages are highly specific, attacking only certain bacterial species while leaving the normal microbiome intact, and that they can penetrate bacterial biofilms that antibiotics cannot. Its website also presents educational content on the history and mechanism of bacteriophages and cites clinical research, such as a 2016 study in Saint Petersburg comparing phage and antibiotic treatment of bacterial vaginosis and vaginitis. The company operates in the Russian market and sells through its own website and, presumably, pharmacies and other retail channels. Ownership, founding year and corporate structure are not disclosed in the available sources; Wikidata simply describes it as a company in Moscow, Russia.

MicroMir (НПЦ «Микромир») is a Russian research-and-production centre based in Moscow. The available sources do not specify its founding date or corporate history in detail, but its website and product pages indicate that it was established as a centre specialising in bacteriophage research and the development of phage-based consumer health products. The company's name, "MicroMir" (Микромир), means "microworld" in Russian, reflecting its focus on the microscopic world of bacteria and bacteriophages. The company's core activity is the development of gels containing cocktails of bacteriophages — viruses that infect and destroy specific bacteria. MicroMir's microbiologists analyse which bacteria most frequently cause problems in different parts of the body and select phages active against them. This approach has resulted in a line of four flagship gels: Otofag for ENT organs, Fagodent for the oral cavity, Fagoderm for the skin, and Fagogin for intimate hygiene. Each gel contains a defined number of phage types (74, 73, 73 and 70 respectively) and is presented in a 50 ml tube. MicroMir positions its products as a natural means of normalising the microbiome and providing antibacterial protection, and states that they can be used together with antibiotics. The company emphasises the specificity of phages, which attack only certain bacteria and leave the normal microbiome intact, and their ability to penetrate bacterial biofilms that protect bacteria from antibiotics. Its website also provides educational material on the history of bacteriophages, their mechanism of action, and clinical research, including a 2016 study in Saint Petersburg that compared phage and antibiotic treatment of bacterial vaginosis and vaginitis. The company operates in the Russian market. Its products are sold through its website and likely through pharmacies and other retail channels. As of the available evidence, MicroMir remains an active company; no information on ownership, parent company, or stock listing is provided.

Natural, microbiome-friendly antibacterial protection based on bacteriophages, positioned as an alternative or complement to antibiotics.

• Otofag (Отофаг)

  Gel with 74 bacteriophages, 50 ml, for the hygiene and protection of ENT organs (ear, throat, nose). Indicated for ARVI, rhinitis, otitis, sinusitis, pharyngitis, adenoiditis, tonsillitis, laryngitis, chronic tonsillitis. Can be used with antibiotics.

• Fagodent (Фагодент)

  Gel with 73 bacteriophages, 50 ml, for oral hygiene and protection against gingivitis, stomatitis, periodontitis, periodontosis and other inflammatory processes. Contains calendula extract; no dyes or fragrances. Can be used for babies during teething.

• Fagoderm (Фагодерм)

  Gel with 73 bacteriophages, 50 ml, for the care of oily, damaged and problem skin. Helps preserve the microbiome and prevents the growth of 'bad' bacteria in skin diseases.

• Fagogin (Фагогин)

  Gel with 70 bacteriophages, 50 ml, for everyday intimate hygiene for women and men. Protects against bacterial infections, helps with chronic cystitis and vaginitis, and complements complex treatment of chronic and recurrent diseases.

1. 1Бактериофаги для защиты здоровья: гели от НПЦ Микромирmicromir.bio
2. 2Отофаг: гель с бактериофагами для защиты ЛОР-органов | НПЦ Микромирmicromir.bio
3. 3Фагогин: гель с бактериофагами для интимной гигиены | НПЦ Микромирmicromir.bio
4. 4Фагодент: гель с бактериофагами для защиты полости рта | НПЦ Микромирmicromir.bio
5. 5MicroMirwikidata.org